Nephros Covid-19 Operational Update


The SequaPathTM system provides the capability to screen water for over 20,000 different bacterial genera (families), including genera of the 40+ pathogenic bacteria listed by the Centers for Disease Control & Prevention (CDC) (Opportunistic Pathogens of Premise Plumbing). The system incorporates Nephros’ proprietary filtration technology and a DNA sequencing step that makes it possible to screen rapidly for genera of waterborne pathogens. The SequaPath™ platform is portable, allowing for same-day on-site analysis.

SequaPath Graphic

Questions about SequaPath™? Contact us today.

nephros contact email